This stock is in the doghouse; is it a buy?

Greencross Limited (ASX:GXL) has plunged 40% from its 52-week high, but is now the right time to start buying?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There is little doubt Australians love their pets and this relationship is expected to grow even stronger as more people treat their pets like family. One company that is looking to take advantage of this trend is Greencross Limited (ASX: GXL). It is Australia's leading provider of specialist veterinary services and owns retail outlets Petbarn and City Farmers.

Greencross currently controls around 8% of the pet market with the aim of increasing this to 20%. With the market growing at around 4% per annum, the sector fundamentals are attractive and should provide Greencross with opportunities for growth organically and through acquisition.

Much of the previous growth Greencross has enjoyed has been attributed to its 'roll up' strategy. The company looks to acquire complementary businesses at an attractive price that can be integrated into its current business model. While this strategy has been successful in the past, some are questioning whether this is a sustainable strategy in the future and that has driven the share price down.

The share price has continued to be under pressure since an update to the market in May. Greencross revised underlying earnings growth to between 40%-46% as a result of several unexpected factors. The most concerning is the impact of the slowing Western Australia economy. WA makes up 15% of its store network and any further slowing will impact the ability of the company to meet its guidance. Severe weather conditions in Queensland and New South Wales have also affected trading as well as causing supply chain disruptions, which have now been rectified. On the positive side, the company has maintained its like-for-like sales within the target range despite those factors.

These short-term headwinds and concern about its "roll up" strategy has seen the share price fall from a high of $10.78 to a recent low of $6.14. With a historical growth rate of over 25% per year since 2011, Greencross has a history of strong financial performance and accordingly has been priced for growth. It is currently trading on a forward price-to-earnings ratio of around 19 times and a growing dividend yield of around 2.8%. The fundamentals for Greencross are still very strong and the recent fall may provide long-term investors with a good entry point.

Greencross is still rolling out new stores and acquiring clinics while integrating recent acquisitions. The management team has shown it has expertise in sourcing acquisitions and with a fragmented market, the company still has the ability to consolidate the market further. The key to its future success will be ensuring it does not pay a premium for these acquisitions.

Foolish takeaway

Greencross operates in a market that is growing faster than the broader economy and has a strong competitive position within the market. It is these fundamentals that should see Greencross deliver market-beating results over the long term. I think Greencross is a buy at current prices.

Motley Fool contributor Christopher Georges owns shares in Greencross Limited.  Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »